ELIQUIS 2.5 MG 10 TABLETS | Apixaban Anticoagulant Medicine
ELIQUIS 2.5 MG 10 TABLETS contain Apixaban 2.5 mg, a prescription direct Factor Xa inhibitor used to help prevent and treat blood clots and reduce the risk of stroke in eligible patients.
ELIQUIS 2.5 MG 10 TABLETS
ELIQUIS 2.5 MG TABLETS (Apixaban 2.5 mg): Comprehensive Guide and Benefits
Introduction to ELIQUIS 2.5 MG TABLETS
Direct Factor Xa Inhibitor Anticoagulant
ELIQUIS 2.5 MG 10 TABLETS contain Apixaban 2.5 mg, a prescription Direct Factor Xa Inhibitor and Novel Oral Anticoagulant (NOAC). It is used to help prevent and treat blood clots and reduce the risk of stroke and systemic embolism in eligible patients with certain cardiovascular conditions.
Prescription Status: Prescription-only medicine. Use only under the supervision of a qualified healthcare professional.
Key Benefits of ELIQUIS 2.5 MG TABLETS
Helps prevent the formation of harmful blood clots.
Supports the treatment of existing blood clots.
Helps reduce the risk of stroke and systemic embolism in eligible patients.
Provides predictable anticoagulant activity with fixed dosing.
Does not generally require routine INR monitoring.
Composition
Active Ingredient:
Apixaban – 2.5 mg
Dosage Form:
Film-Coated Tablet
Pack Size:
10 Tablets
Drug Class
Direct Factor Xa Inhibitor
Novel Oral Anticoagulant (NOAC)
Therapeutic Category
Anticoagulant
Cardiovascular Medicine
How ELIQUIS 2.5 MG Works
Apixaban selectively inhibits Factor Xa, a key enzyme in the blood clotting cascade. By reducing thrombin generation, it helps prevent the formation and enlargement of blood clots while maintaining effective anticoagulation.
Usage Instructions
Take ELIQUIS 2.5 MG TABLETS exactly as prescribed by your doctor.
Swallow the tablet whole with water.
It may be taken with or without food.
Take the medicine at the same time each day.
Do not stop taking the medicine without consulting your healthcare provider.
Medicinal Advantages
Effective Blood Clot Prevention
Helps reduce the risk of harmful clot formation through targeted inhibition of Factor Xa.
Predictable Anticoagulant Effect
Provides consistent anticoagulant activity with fixed-dose therapy in appropriate patients.
No Routine INR Monitoring
Unlike vitamin K antagonists such as warfarin, routine INR monitoring is generally not required.
Convenient Oral Therapy
Available as an oral tablet suitable for long-term anticoagulation under medical supervision.
Mechanism of Action
Apixaban directly inhibits Factor Xa, preventing the conversion of prothrombin into thrombin. This decreases fibrin clot formation and helps reduce the risk of thromboembolic events.
Off-Label Uses
Healthcare professionals may prescribe Apixaban for conditions outside its approved indications when clinically appropriate.
Expert Advice
Take the medicine exactly as prescribed.
Do not miss doses or discontinue treatment without medical advice.
Inform all healthcare providers and dentists that you are taking an anticoagulant.
Inform your doctor about all medicines, supplements, and herbal products you use.
Attend regular medical follow-up appointments as recommended.
Precautions
Use only under medical supervision.
Inform your doctor if you have kidney disease, liver disease, or bleeding disorders.
Consult your doctor before use during pregnancy or breastfeeding.
Your doctor may advise temporary discontinuation before surgery or certain medical procedures.
Storage Instructions
Store below 30°C.
Keep the tablets in the original packaging.
Protect from moisture and direct sunlight.
Keep out of reach of children.
Frequently Asked Questions (FAQs)
Q: What is the active ingredient in ELIQUIS 2.5 MG TABLETS?
A: Each tablet contains Apixaban 2.5 mg.
Q: What drug class does ELIQUIS 2.5 MG belong to?
A: ELIQUIS 2.5 MG belongs to the Direct Factor Xa Inhibitor class of anticoagulant medicines.
Q: Can ELIQUIS 2.5 MG be taken with food?
A: Yes. It may be taken with or without food, as directed by your healthcare professional.
Q: Is ELIQUIS 2.5 MG a prescription medicine?
A: Yes. ELIQUIS 2.5 MG TABLETS are prescription-only and should be used under the supervision of a qualified healthcare professional.
Q: Does ELIQUIS 2.5 MG require routine INR monitoring?
A: Routine INR monitoring is generally not required with Apixaban therapy, although regular medical follow-up remains important.
Product Tags
ELIQUIS 2.5 MG 10 TABLETS, Apixaban 2.5 mg Tablet, Direct Factor Xa Inhibitor, Novel Oral Anticoagulant, NOAC, Blood Thinner Tablets, Prescription Anticoagulant, Cardiovascular Medicine.
